elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28252207-D1C01397-99E6-449C-B907-6D7E70C75047
Q28252207-D1C01397-99E6-449C-B907-6D7E70C75047
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-D1C01397-99E6-449C-B907-6D7E70C75047
Risks and benefits of infliximab for the treatment of Crohn's disease
P433
Q28252207-D1C01397-99E6-449C-B907-6D7E70C75047
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-D1C01397-99E6-449C-B907-6D7E70C75047
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
58660efd1d48394ce5568d0d2680f00c3696d4f3
P433
8
http://www.w3.org/2001/XMLSchema#string